Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2876627 | The Annals of Thoracic Surgery | 2014 | 7 Pages |
Abstract
Robotic lobectomy for cancer offers outstanding results, with excellent lymph node removal and minimal morbidity, mortality, and pain. Despite its costs, it is profitable for the hospital system. Disadvantages include capital costs, the learning curve for the team, and the lack of lung palpation. Robotic surgery is an important tool in the armamentarium for the thoracic surgeon, but its precise role is still evolving.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Basil S. MBBCh, Ayesha S. MSPH, MD, Douglas J. MD, Ben MD, Robert J. MD, MBA,